地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18372041646
传真：18995651644
邮箱：sales@amyjet.com
<艾美捷科技代理Helvetica Health Care品牌全系列产品
Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司，致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员，Helvetica Health Care通过了ISO 13485认证，在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板，适用于不同的分子测试平台和检测。这些产品有多种规格，可用于单一或多种分析物的检测，帮助实验室监控测试性能，确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制，满足不同平台的需求。
▎Helvetica Health Care产品线
Helvetica Health Care公司的产品涵盖：抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。
▎Helvetica Health Care部分产品列表
| 货号 | 产品描述 |
| NATFRC-6C | NATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL) |
| NATCV9-6C | NATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL) |
| NATRPC2.1-BIO | NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) |
| NATRVP2.1-BIO | NATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA) |
| NATRVP2.1-BIO Plus | NATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml) |
| NATRVP2-QIA | NATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA) |
| NATSARS(COV2)-VP | NATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL) |
| NATSARS(COV2)-ERC | SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL) |
| NATSARS(COV2)-ERC1 | NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml) |
| NATSARS(COV2)-NEG | SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL) |
| NATSARS(COV2)-NEG1 | NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml) |
| NATSARS(COV2)-ST | SARS-Related Coronavirus 2 (SARS-CoV-2) Stock |
| NATSARS(COV2-SA)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL) |
| NATSARS(COV2-UK)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL) |
| 0810229-0.5mg | Coronavirus 229E Lysate (0.5 mg) |
| 0810587 | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg) |
| 0810587-0.5mg | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg) |
| 0810587CFHI-0.5mL | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL) |
| 0810587CFHI | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL) |
| 0810587UV | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL) |
| 0810589CFHI | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810589UV | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL) |
| 0810590CFHI | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810590UV | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL) |
| 0810617UV | SARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV)) |
| 0810618UV | SARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV) |
| 0810619UV | SARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated) |
| 0810620UV | SARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated) |
| 0810621UV | SARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated) |
| 0810622UV | SARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated) |
| 0810612CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810612UV | SARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL) |
| 0810613CFHI | SARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL) |
| 0810613UV | SARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL) |
| 0810614CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810614UV | SARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL) |
| 0810616CFHI | SARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL) |
| 0810616UV | SARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL) |
| 0810617CFHI | SARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml) |
| 0810618CFHI | SARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml) |
| 0810619CFHI | SARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml) |
| 0810620CFHI | SARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml) |
| 0810621CFHI | SARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml) |
| 0810622CFHI | SARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml) |
| 0810623UV | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated) |
| 0810623CFHI | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated) |
| 0810624UV | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated) |
| 0810624CFHI | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated) |
| 0820010CFHI | VeroE6 Culture Fluid (Heat Inactivated) (1 mL) |
| 0801043 | Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml) |
| 0831042 | SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL) |
| 0831043 | SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL) |
| NATSARS-ST | Coronavirus SARS Stock (Qualitative) (1 mL) |
| NATCOV(229E)-ST | Coronavirus 229E Stock (Qualitative) (1 mL) |
| 0810229CFHI | Coronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810229 | Coronavirus Strain: 229E Lysate |
| 0810229UV | Coronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL) |
| NATCOV(NL63)-ST | Coronavirus NL63 Stock (Qualitative) (1 mL) |
| 0810228CFHI | Coronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810228 | Coronavirus Strain: NL63 Lysate |
| 0810228UV | Coronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL) |
| NATCOV(OC43)-ST | Coronavirus OC43 Stock (Qualitative) (1 mL) |
| 0810024CFHI | Coronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810024 | Coronavirus Strain: OC43 Lysate |
| NATMERS-ST | MERS-CoV Stock (Qualitative) (1 mL) |
| NATMR-BIO | NATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml) |
| NATCOV(MR)-BIO | NATtrol MERS-S. Cerevisiae (0.6 ml) |
| 0810575 | MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg) |
| 0810575-0.5mg | MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg) |
| CV033122 | COVID-19 Cross Over Panel (40x 1.0 ml) |
invivoCrown IV0119替换BioXCell BE0004-1
invivoCrown IV0117替换BioXCell BE0223
invivoCrown IV0118替换BioXCell BE0055
艾美捷科技特约代理Arbor Assays的全系列产品。
Arbor Assays公司成立于2007年，位于密歇根州的安娜堡，公司的三位主创始人均为有多年科研经验的生命和临床科学家。其宗旨是为临床使用的重要生物分子建立高质量的检测和免疫测试产品。在生物领域建立健全的免疫检测和酶活性试剂盒以定量生物分子。
Arbor Assays公司的主要产品包括：
DetectX® Kits
Inhibitors & Activators
AbX® Antibodies & Affinity Resins
Detection Systems
Components & Ancillary Reagents
" data-original="http://hypoxyprobe.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Arbor Assays"> Arbor Assays invivoCrown IV0120替换BioXCell BE0015-1
invivoCrown IV0119替换BioXCell BE0004-1
invivoCrown IV0120替换BioXCell BE0015-1
<艾美捷科技代理VIDIA品牌全系列产品
VIDIA Ltd.是一家捷克私营生物技术公司，创立于1991年，是体外诊断试剂（IVD）生产商，产品应用于人类医学诊断和环境监测领域。自2003年起，公司已通过ISO 9001和ISO 13485认证。所有IVD产品均获得CE认证。其产品设计具有高稳定性和长保质期，且易于使用。
▍VIDIA公司产品线
● ELISA-VIDITEST™ 免疫酶联检测试剂盒：基于酶联免疫吸附法，具有抗体定量/半定量/定性分析、鞘内抗体合成测定以及抗体亲和力评估的检测功能。
● MONO-VIDITEST™ 单次检测盒：基于间接ELISA方法，用于测定样品中特异性抗体的含量。这些试剂盒旨在对血清、血浆、脑脊液和滑膜液样本中的 IgA、IgM 和 IgG 类抗体进行定量/半定量评估。
● LIA-VIDITEST：基于硝酸纤维素膜条的酶联线性免疫印迹法，单次运行即可并行检测多个样本的 IgM 和 IgG 抗体，经验证适用于全自动或半自动的 RoboBlot、BeeBlot、B20 分析仪。
● RAPID-VIDITEST 快速检测试剂盒：诊断型快速色谱免疫分析法，操作简便，结果易判读，可定性检测多种病毒、细菌、寄生虫的抗原。
● IF-VIDITEST：应用于多种感染的血清学诊断，具有高灵敏度与高特异性，操作流程简便的特点。
▍VIDIA部分产品列表
| 品名 | 规格 | 货号 |
| ELISA-VIDITEST anti-complement factor H | 48 wells quantitative | ODZ-166 |
| ELISA-VIDITEST EDUCO Diagnostic | 96 wells 6 doublestrips | ODZ-191 |
| CMV - CI combi r.t.u. | 1 ml | ODZ-264 |
| VZV - CI combi r.t.u. | 1 ml | ODZ-289 |
| HSV-1 - CI nativ r.t.u. | 1 ml | ODZ-314 |
| HSV-2 - CI nativ r.t.u. | 1 ml | ODZ-315 |
| CMV - CI nativ conc. | 0,5 mg | ODZ-319/05 |
| VZV - CI nativ conc. | 0,1 mg | ODZ-320 |
| HSV-1 - CI nativ conc. | 0,1 mg | ODZ-321 |
| HSV-2 - CI nativ conc. | 0,1 mg | ODZ-322 |
| Control - CI r.t.u. (pro CMV, VZV) | 1 ml | ODZ-365 |
| Control - CI r.t.u. (pro HSV-1, HSV-2) | 1 ml | ODZ-366 |
| ELISA-VIDITEST Bisphenol A | 96 wells quantitative | ODZ-041 |
| ELISA-VIDITEST Microcystin-LR | 96 wells quantitative | ODZ-165 |
| ELISA-VIDITEST pNF-H (Neurofilament-H) | 96 wells quantitative | ODZ-437 |
| ELISA-VIDITEST anti-HSV1+2 IgG | 96 wells semiquantitative | ODZ-169 |
| ELISA-VIDITEST anti-HSV1+2 IgM | 96 wells semiquantitative | ODZ-234 |
| ELISA-VIDITEST anti-HSV1+2 IgA | 96 wells semiquantitative | ODZ-283 |
| MONO-VIDITEST anti-HSV IgG | 12 tests | KZ-140-12 |
| MONO-VIDITEST anti-HSV IgM | 12 tests | KZ-141-12 |
| ELISA-VIDITEST anti-EBNA-1 EBV IgG, doublestrip | 96 wells semiquantitative | ODZ-015 |
| ELISA-VIDITEST anti-EBNA-1 EBV IgG | 96 wells semiquantitative | ODZ-001 |
| ELISA-VIDITEST anti-EBNA-1 EBV IgM | 96 wells semiquantitative | ODZ-002 |
| ELISA-VIDITEST anti-VCA EBV IgG | 96 wells semiquantitative | ODZ-265 |
| ELISA-VIDITEST anti-VCA EBV IgG (CSF) | 96 wells quantitative | ODZ-084 |
| ELISA-VIDITEST anti-VCA EBV IgG and IgG avidity | 96 wells semiquantitative | ODZ-175 |
| ELISA-VIDITEST anti-VCA EBV IgM | 96 wells semiquantitative | ODZ-005 |
| ELISA-VIDITEST anti-VCA EBV IgA | 96 wells semiquantitative | ODZ-096 |
| ELISA-VIDITEST anti-EA (D) EBV IgG | 96 wells semiquantitative | ODZ-006 |
| ELISA-VIDITEST anti-EA (D) EBV IgM | 96 wells semiquantitative | ODZ-007 |
| ELISA-VIDITEST anti-EA (D) EBV IgA | 96 wells semiquantitative | ODZ-254 |
| MONO-VIDITEST anti-VCA EBV IgG | 12 tests | KZ-100-12 |
| MONO-VIDITEST anti-VCA EBV IgM | 12 tests | KZ-101-12 |
| MONO-VIDITEST anti-VCA EBV IgA | 12 tests | KZ-102-12 |
| MONO-VIDITEST anti-VCA EBV IgG avidita | 12 tests | KZ-103-12 |
| MONO-VIDITEST anti-EBNA-1 EBV IgG | 12 tests | KZ-110-12 |
| MONO-VIDITEST anti-EBNA-1 EBV IgM | 12 tests | KZ-111-12 |
| ELISA-VIDITEST anti-CMV IgG (CSF) | 96 wells quantitative | ODZ-102 |
| ELISA-VIDITEST anti-CMV IgG and IgG avidity | 96 wells semiquantitative | ODZ-177 |
| ELISA-VIDITEST anti-CMV IgM | 96 wells semiquantitative | ODZ-402 |
| ELISA-VIDITEST anti-CMV IgA | 96 wells semiquantitative | ODZ-164 |
| ELISA-VIDITEST anti-VZV IgG | 96 wells semiquantitative | ODZ-168 |
| ELISA-VIDITEST anti-VZV IgG (CSF) | 96 wells quantitative | ODZ-087 |
| ELISA-VIDITEST anti-VZV IgG and IgG avidity | 96 wells semiquantitative | ODZ-233 |
| ELISA-VIDITEST anti-VZV IgM | 96 wells semiquantitative | ODZ-197 |
| ELISA-VIDITEST anti-VZV IgA | 96 wells semiquantitative | ODZ-284 |
| MONO-VIDITEST anti-EA(D) EBV IgG | 12 tests | KZ-120-12 |
| MONO-VIDITEST anti-EA(D) EBV IgM | 12 tests | KZ-121-12 |
invivoCrown IV0100替换BioXCell BE0146
地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：13212737804
传真：18372041646
邮箱：sales@amyjet.com
0.1189